Literature DB >> 32716080

Chemical constituents, clinical efficacy and molecular mechanisms of the ethanol extract of Abelmoschus manihot flowers in treatment of kidney diseases.

Nan Li1,2, Haitao Tang3, Liang Wu4,5, Haitao Ge3, Yurong Wang1, Honglin Yu3, Xiuli Zhang6, Jimei Ma3, Harvest F Gu1.   

Abstract

Abelmoschus manihot, also called as "Huangkui" in Chinese, is an annual flowering herb plant in the family of Malvaceae. As a traditional Chinese medicine, the ethanol extract of the flower in Abelmoschus manihot is made as Huangkui capsule and has been used for medication of the patients with kidney diseases. Its efficacy in clinical symptoms is mainly improving renal function and reducing proteinuria among the patients with chronic kidney disease, diabetic kidney disease or IgA nephropathy. The possible mechanism of Huangkui capsule treatment in kidney diseases may include reducing inflammation and anti-oxidative stress, improving immune response, protecting renal tubular epithelial cells, ameliorating podocyte apoptosis, glomerulosclerosis and mesangial proliferation, as well as inhibiting renal fibrosis. In this review, we first described chemical constituents and pharmacokinetic characteristics in ethanol extract of the flower of Abelmoschus manihot. We then summarized the clinical and epidemiological relevancies of kidney diseases particularly in the mainland of China and discussed the possible molecular mechanisms of Huangkui capsule in the treatment of kidney diseases. Finally, we prospected further research on cellular and molecular mechanisms and application of this Chinese natural medicine in kidney diseases.
© 2020 The Authors. Phytotherapy Research published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Abelmoschus manihot; Huangkui capsule; IgA nephropathy; chronic kidney disease; diabetic kidney disease

Year:  2020        PMID: 32716080     DOI: 10.1002/ptr.6818

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  11 in total

1.  Aerobic exercise training combined or not with okra consumption as a strategy to prevent kidney changes caused by metabolic syndrome in Zucker rats.

Authors:  Monique Marques da Silva; Moisés Felipe Pereira Gomes; Elizabeth de Orleans Carvalho de Moura; Mariana Matera Veras; Melina Chiemi Kubota; Ana Paula Takano; Ana Carolina Cardoso Dos Santos; Carolina Gonçalves Dos Reis José; Graziele Aparecida da Silva Souza; Naiara Magalhães Cardoso; Debora Estadella; Rafael Herling Lambertucci; Alessandra Medeiros
Journal:  PLoS One       Date:  2022-06-03       Impact factor: 3.752

2.  Efficacy of Combined Abelmoschus manihot and Irbesartan for Reduction of Albuminuria in Patients With Type 2 Diabetes and Diabetic Kidney Disease: A Multicenter Randomized Double-Blind Parallel Controlled Clinical Trial.

Authors:  Jing Zhao; Isabelle Tostivint; Lingdong Xu; Jihan Huang; Laetitia Gambotti; Jean-Jacques Boffa; Min Yang; Ling Wang; Zhuxing Sun; Xiaolan Chen; Amélie Liou-Schischmanoff; Alain Baumelou; Teng Ma; Guoyuan Lu; Ling Li; Dai Chen; Laurence Piéroni; Bingkai Liu; Xiao Qin; Weiming He; Yuejuan Wang; Harvest F Gu; Wei Sun
Journal:  Diabetes Care       Date:  2022-07-07       Impact factor: 17.152

3.  Total Flavones of Abelmoschus manihot Remodels Gut Microbiota and Inhibits Microinflammation in Chronic Renal Failure Progression by Targeting Autophagy-Mediated Macrophage Polarization.

Authors:  Yue Tu; Qi-Jun Fang; Wei Sun; Bu-Hui Liu; Ying-Lu Liu; Wei Wu; Hong-Yun Yee; Can-Can Yuan; Mei-Zi Wang; Zi-Yue Wan; Ren-Mao Tang; Yi-Gang Wan; Hai-Tao Tang
Journal:  Front Pharmacol       Date:  2020-09-30       Impact factor: 5.810

4.  IgA nephropathy treatment with traditional Chinese medicine: A case report.

Authors:  Ying-Yu Zhang; Yan-Lin Chen; Lan Yi; Kun Gao
Journal:  World J Clin Cases       Date:  2022-04-06       Impact factor: 1.534

5.  Quercetin improves contrast-induced acute kidney injury through the HIF-1α/lncRNA NEAT1/HMGB1 pathway.

Authors:  Min Luo; Ziyu Liu; Zongren Hu; Qinghu He
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

Review 6.  The Therapeutic Strategies for Uremic Toxins Control in Chronic Kidney Disease.

Authors:  Ping-Hsun Lu; Min-Chien Yu; Meng-Jiun Wei; Ko-Lin Kuo
Journal:  Toxins (Basel)       Date:  2021-08-17       Impact factor: 4.546

7.  Efficacy and safety of Huangkui capsule for diabetic nephropathy: A protocol for systematic review and meta-analysis.

Authors:  Wenrong An; Yanqin Huang; Shouqiang Chen; Tao Teng; Juan Liu; Yunsheng Xu
Journal:  Medicine (Baltimore)       Date:  2021-10-22       Impact factor: 1.817

8.  Exploring the total flavones of Abelmoschus manihot against IAV-induced lung inflammation by network pharmacology.

Authors:  Yanan Gao; Zihao Liang; Nianyin Lv; Jinjun Shan; Huihui Zhou; Junfeng Zhang; Liyun Shi
Journal:  BMC Complement Med Ther       Date:  2022-02-05

9.  Effects of Abelmoschus manihot Flower Extract on Enhancing Sexual Arousal and Reproductive Performance in Zebrafish.

Authors:  Chi-Chang Chang; Jer-Yiing Houng; Wei-Hao Peng; Tien-Wei Yeh; Yun-Ya Wang; Ya-Ling Chen; Tzu-Hsien Chang; Wei-Chin Hung; Teng-Hung Yu
Journal:  Molecules       Date:  2022-03-29       Impact factor: 4.411

10.  Total Flavones of Abelmoschus manihot Ameliorates Podocyte Pyroptosis and Injury in High Glucose Conditions by Targeting METTL3-Dependent m6A Modification-Mediated NLRP3-Inflammasome Activation and PTEN/PI3K/Akt Signaling.

Authors:  Bu-Hui Liu; Yue Tu; Guang-Xia Ni; Jin Yan; Liang Yue; Zi-Lin Li; Jing-Jing Wu; Yu-Ting Cao; Zi-Yue Wan; Wei Sun; Yi-Gang Wan
Journal:  Front Pharmacol       Date:  2021-07-15       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.